A bdominal aortic aneurysm (AAA), characterized by chronic aortic wall inflammation and destructive connective tissue remodeling, is one of the leading causes of sudden death in aging men (>55 years). 1 Despite the current progress of surgical invasive repair or medical treatment, we lack a strategy to predict AAA rupture or to delay its progression. Epidemiological studies have identified several risk factors associated with AAA, including aging, male sex, smoking, and hypertension. 1-3 However, the cause of AAA remains far from being fully elucidated.
the association of HHcy and AAA is still an enigma. A number of observational studies have found a high level of Hcy in patients with AAA. [6] [7] [8] [9] [10] However, reports from existing retrospective studies are not consistent. 11, 12 Also, although some groups reported that patients with AAA are more likely to be homozygous for the T allele variant of the methylenetetrahydrofolate reductase gene responsible for HHcy, others did not confirm the observation. 13, 14 Whether Hcy plays a causal role or is just acting as a bystander in the pathogenesis of aneurismal disease remains elusive.
Vascular inflammation is the hallmark of AAA and also is evident in other cardiovascular diseases, including atherosclerosis. 1, 3, 15 The traditional view of vascular inflammation involves an inside-out response-it begins with endothelial activation and leukocyte extravasation, and progresses outward toward the adventitia. However, over the past decades, a new outside-in hypothesis has emerged, whereby vascular wall inflammation is initiated in the adventitial layer and progresses through the media inward, toward the intima. 16, 17 Infiltrations of macrophages, T lymphocytes, and B lymphocytes are mainly observed in the tunica adventitia of human aneurismal tissue. 18, 19 Recent studies have shown that leukocyte-fibroblast interaction in the aortic adventitia accelerates macrophagemediated vascular inflammation, thus leading to aortic dissection in mice. 20, 21 Nevertheless, the precise role of adventitia fibroblasts in the vascular inflammation of AAA is unclear.
In the current study, we first performed a meta-analysis to assess the relationship between HHcy and AAA in the literature. Then, by use of an animal AAA model induced by angiotensin II (Ang II) in 3-month-old male apolipoprotein E-deficient (ApoE −/− ) mice, we studied the effect of HHcy on AAA formation. Our findings suggest that even mild HHcy may be related to AAA and aggravate AAA. Notably, HHcy exacerbated adventitial inflammation, which was mediated mainly through NADPH oxidase 4 (Nox4) in adventitial fibroblasts.
Methods
Eligible studies for meta-analysis were identified by searching PubMed and Embase for relevant reports published before March 2012, with the search terms homocysteine, hyperhomocysteinemia, abdominal aortic aneurysm, or MTHFR allele. All animal studies followed the guidelines of the Animal Care and Use Committee of Peking University. Male ApoE −/− mice aged 12 weeks were fed with normal mouse chow supplemented with or without 1.8 g/L Dex-and Leyo-Hcy (Sigma) in drinking water for 4 weeks as described. 3 Alzet osmotic minipumps (model 2004) containing 1000 ng/kg per minute Ang II or saline were implanted subcutaneously into ApoE −/− mice for infusion for an additional 28 days, respectively. 4 The AAA is defined as a 50% increase in external diameter of the abdominal aorta. 4, 6 Total plasma Hcy level was quantified by enzymatic cycling assay as described. 9 Rat adventitial fibroblasts were isolated from the aortas of Sprague-Dawley rats (150-180 g) and cultured in DMEM supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO 2 . The purity of primary adventitial fibroblasts was verified by positive immunofluorescent staining of vimentin and negative staining for smooth muscle (SM) α-actin and SM22α. Small interfering RNA against Nox4 involved use of Oligofectamine (Invitrogen). Intracellular reactive oxygen species (ROS) generation was monitored by use of Amplex Red (Invirogen) spectrophotometrically.
An expanded and detailed Materials and Methods section is available in the Online Data Supplement.
Results

Meta-Analysis Suggests a Strong Association of HHcy and AAA
Among 75 publications with relevant data, we identified 6 case-control studies that met our inclusion criteria (Online Table I ). The definition of HHcy in all studies was comparable, with plasma Hcy concentration ranging from 15 to 19 μmol/L. The pooled odds ratio for 1489 participants of 6 studies was 7.39 (95% CI, 3.71-14.72), which indicated that even a mild increase in Hcy was associated with risk of AAA ( Figure 1 , Online Table I ). We found no evidence of publication bias as assessed by Begg test (P=0.260, Online Figure I ), but we found significant heterogeneity among studies (I 2 =70.5%; P=0.005). Of interest, the in-group heterogeneity was significantly reduced, whereas further subgroup meta-analysis was performed according to region/country. In contrast, the heterogeneity was not affected by age and sex (Online Table II ).
HHcy Aggravates Ang II-Induced Aortic Aneurysm
Three-month-old male ApoE −/− mice were divided into 4 groups for treatment: control, vehicle plus saline infusion (n=9); HHcy, Hcy (1.8 g/L Dex-and Leyo-Hcy daily in drinking water) plus saline infusion (n=9); Ang II, vehicle plus Ang II infusion (n=19); and Ang II plus HHcy, Hcy in drinking water plus Ang II infusion (n=19) (Online Figure  II) . No significant aortic aneurysm developed in the control group or the HHcy group infused with saline. Within the Ang II group, 3 mice died accidentally because of surgery within the first 2 days after treatment with Ang II. Among the 16 mice left, 5 mice died at an early stage because of thoracic aortic dissection (n=3; Online Figure III ) and rupture of AAA (n=2) during the infusion period. At the end of week 4, chronic infusion of Ang II induced suprarenal aneurysm in 3 ApoE −/− mice (Online Table V ). Together, there was a combined end point of aneurysm development and aortic rupture in 50% of the mice (8/16; Figure 2A and 2B), which was Table V) . Therefore, the total incidence of aortic aneurysm formation and rupture was 100% in the Ang II plus HHcy group ( Figure  2B ). HHcy also markedly enhanced the severity of aortic aneurysm, as reflected by maximal abdominal aortic diameter and elastic lamina disruption ( Figure 2C-2E ). Of note, Ang II infusion increased blood pressure, but HHcy did not further significantly elevate blood pressure (Online Figure IV) . HHcy had no effect on body weight or plasma total cholesterol and total triglyceride levels (Online Table III ). Therefore, HHcy aggravated the incidence of aortic aneurysm and severity in Ang II-infused ApoE −/− mice, without increasing blood pressure or plasma lipid level.
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HHcy Amplifies Suprarenal Aortic Adventitial Inflammation in Ang II-Infused ApoE −/− Mice
Aortic aneurysm and rupture are mainly characterized by extensive vascular inflammation and disruption of structural extracellular matrix. Administration of Ang II significantly increased inflammatory cells, such as CD45 + leukocytes, mouse CD107b (Mac3 + ) macrophages, and CD45 + T lymphocytes infiltration into tunica adventitia of ApoE −/− mice ( Figure 3A ), which is consistent with observations in human aneurismal tissue. 18, 19 Furthermore, HHcy greatly enhanced Ang II-evoked inflammatory cell recruitment in adventitia. Similarly, matrix-degrading metalloproteinase activity, as seen by in situ zymography, was markedly increased in the vascular wall of Ang II-treated ApoE −/− mice with HHcy, particularly in adventitia ( Figure 3B ). Of note, Hcy alone significantly induced macrophage infiltration in saline-infused ApoE −/− mice as compared with control, although to a lesser extent than with Ang II. The amplification of Ang II-induced inflammation by HHcy was reinforced with HHcy exaggerating plasma levels of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) in Ang II-treated ApoE −/− mice ( Figure 3C ). IL-6 is a proinflammatory cytokine and MCP-1 is a proinflammatory chemokine pivotal for aneurysm formation and mainly originate from the inflamed vascular wall. 20 To further characterize the mechanism by which HHcy exaggerated vascular inflammation, we analyzed the expression and localization of IL-6 and MCP-1 by immunofluorescence staining. HHcy markedly enhanced the vascular wall production of IL-6 and MCP-1, particularly in the tunica adventitia of the Ang II-treated ApoE −/− mice ( Figure 3D ). Quantitative analysis of abdominal aortic adventitia from the diaphragm to the iliac bifurcation revealed higher expression of MCP-1 and IL-6 mRNA in the HHcy plus Ang II group compared with that of Ang II alone ( Figure 3E ; n=3).
Hcy Stimulates Adventitial Fibroblasts Secretion of MCP-1 and IL-6
Next, we analyzed the cellular distribution of IL-6 and MCP-1 in suprarenal aortic adventitia by confocal microscopy. IL-6 and MCP-1 were both localized in macrophage and adventitia fibroblast in Ang II-infused ApoE −/− mice to a similar extent (Online Figure V) . In contrast, in HHcy Ang II-infused ApoE −/− mice, we found preferential expression of IL-6 and MCP-1 in adventitial fibroblasts and, to a lesser extent, in infiltrated macrophages ( Figure 4A ).
The negative controls did not show any specific fluorescence (Online Figure VI) . Accumulating evidence has suggested that aortic adventitial fibroblasts are actively involved in cytokine production, vascular inflammation, and remodeling; therefore, we wondered whether HHcy could activate adventitial fibroblasts to contribute to vascular inflammation. Hcy, 30 μmol/L, greatly enhanced IL-6 and MCP-1 secretion by primary rat adventitial fibroblasts at 72 hours after stimulation, whereas their mRNA levels were induced at 48 hours ( Figure 4B, 4C ). In accordance, Hcy dose-dependently increased IL-6 and MCP-1 production, beginning at a dose of 10 μmol/L and peaking at 100 μmol ( Figure 4D ). Because macrophages are mostly recruited to the adventitia, we wondered whether Hcy enhanced macrophage recruitment to the adventitia by stimulating adventitial fibroblast production of IL-6 and MCP-1. We cocultured THP-1 monocytes/macrophages with human aortic adventitial fibroblasts by use of a transwell system. Hcy-treated adventitial fibroblasts recruited more THP-1 cells than did the vehicle control, and this was greatly abolished by neutralizing antibody of IL-6 and MCP-1 ( Figure 4E ). The data indicate the importance of adventitial fibroblasts−derived cytokines/chemokines in HHcy-induced vascular adventitial inflammation, which agrees with the in vivo observation that HHcy induced inflammatory cell infiltration in the adventitia of salineinfused ApoE −/− mice ( Figure 3A ).
Hcy Induced Adventitial Fibroblast-to-Myofibroblast Differentiation Before Cytokine Secretion
Of note, the mRNA levels of adventitial fibroblast-derived cytokines were not induced by Hcy until 48 hours, so we wondered about the process during that period. Mounting evidence has indicated that with injury, adventitial fibroblasts can undergo differentiation into activated myofibroblasts, which may contribute to cytokine secretion and vascular remodeling, although the precise mechanisms are not fully understood. 16 We monitored the phenotypic transition of adventitial fibroblasts in response to Hcy chronologically in vitro. Intriguingly, Hcy at 30 μmol/L markedly enhanced contractile protein α-actin and SM22α levels in adventitial fibroblasts at approximately 24 hours, which remained elevated up to 48 hours and indicated that Hcy promotes myofibroblast differentiation before cytokine production ( Figure 5A ). In accordance, Hcy from 10 to 100 μmol/L significantly facilitated adventitial fibroblasts differentiation toward myofibroblasts, with a peak at 30 μmol/L ( Figure 5B ). This phenomenon was further verified by immunofluorescence staining of contractile protein ( Figure 5C ).
To confirm the hypothesis in vivo, we analyzed the protein expression of α-actin and SM22α in stripped abdominal aortic adventitial tissue in saline-infused and Ang II-infused ApoE −/− mice. The expressions of α-actin and SM22α were negligible in abdominal aortic adventitia of normal chow-fed ApoE −/− mice, which indicated the predominance of quiescent fibroblasts in tunica adventitia. Ang II infusion significantly elevated α-actin and SM22α levels, which suggests that Ang II promotes myofibroblast differentiation in abdominal aortic adventitia, which agrees with previous results. 21 Interestingly, HHcy alone greatly enhanced α-actin and SM22α levels in adventitia ( Figure 5D , 5E). Therefore, Hcy induced a transition of adventitial fibroblasts to myofibroblasts both in vitro and in vivo.
ROS Mediates Hcy-Induced Adventitial Fibroblast-to-Myofibroblast Differentiation and Cytokine Secretion
To further explore the underlying mechanism of Hcy-induced phenotype transition of adventitial fibroblasts and its potential role in IL-6 and MCP-1 production by adventitial fibroblasts, we first analyzed ROS production in Hcy-treated adventitial fibroblasts. Hcy, 30 μmol/L, greatly evoked ROS production in adventitial fibroblasts as early as 10 minutes, which remained elevated up to 24 hours ( Figure 6A ). Use of the NADPH oxidase inhibitor diphenyliodonium and H 2 O 2 scavenger catalase abolished Hcy-induced upregulation of α-actin and SM22α in adventitial fibroblasts ( Figure 6B ). In contrast, the inhibitor of xanthine oxidase (allopurinol, 10 μmol/L), superoxide dismutase mimic (mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin pentachloride, 25 μmol/L), and an uncoupler of oxidative phosphorylation (carbonyl cyanide 3-chlorophenylhydrazone, 10 μmol/L) showed no effect (Online Figure VII) , which indicates that NADPH oxidase-derived H 2 O 2 mediated Hcy-stimulated transition of adventitial fibroblasts to myofibroblasts. Moreover, diphenyliodonium treatment reversed Hcy-induced IL-6 and MCP-1 secretion by adventitial fibroblasts and subsequent chemotaxis of rat peritoneal macrophage toward Hcy-stimulated adventitial fibroblasts ( Figure 6C, 6D) . Therefore, NADPH oxidase-derived ROS accounted for Hcy-induced myofibroblast differentiation, IL-6 and MCP-1 production, and macrophage recruitment by adventitial fibroblasts.
Hcy Upregulates Nox4 in Adventitial Fibroblasts
Next, we compared the NADPH oxidase homologs Nox1, Nox2, and Nox4 in adventitial fibroblasts. Hcy significantly upregulated the mRNA expression of Nox4, whereas Nox2 was not altered ( Figure 7A ). Interestingly, the mRNA expression of Nox1 was suppressed in adventitial fibroblasts. In addition, the protein level of Nox4 was increased as early as 10 minutes, remained elevated up to 24 hours, and returned to the basal level at 48 hours (Online Figure VIIIA) . Accordingly, Hcy from 10 to 300 μmol/L dose-dependently stimulated Nox4 mRNA level, with a peak at 100 μmol/L (Online Figure  VIIIB) . This observation was verified by Western blot detection and immunofluorescence staining of Nox4 (Online Figures  VIIIC and VIIID) . Additionally, HHcy elevated the Nox4 level in abdominal aortic adventitia (from the diaphragm to the iliac bifurcation) of saline-infused or Ang II-infused ApoE −/− mice (Online Figures VIIIE and VIIIF; n=3) ; therefore, Hcy upregulated adventitial Nox4 both in vitro and in vivo. 
Adventitial Nox4 Mediates Hcy-Induced Myofibroblast Differentiation and Cytokine Production
To further explore the potential role of Nox4 in adventitial fibroblasts activation, we knocked-down Nox4 by small interfering RNA. Nox4 silencing greatly reduced Hcy-evoked ROS production in adventitial fibroblasts, as evidenced by Amplex Red (Figure 7B) . Also, the phenotype transition of adventitial fibroblasts was reversed ( Figure 7C ). Consistently, Hcyenhanced mRNA and protein secretion of IL-6 and MCP-1 ( Figure 7D, 7E) , as well as macrophage recruitment toward adventitial fibroblasts ( Figure 7F) , were abolished. Nox4 may have a pivotal role in adventitial fibroblasts activation and adventitial inflammation.
Smad2/3 Signaling Mediates Hcy-Stimulated Nox4 and Adventitial Fibroblasts Activation
The multifunctional protein transforming growth factor-β (TGFβ) plays an essential role in vascular remodeling by promoting transformation of fibroblasts to myofibroblasts via NADPHderived ROS. Therefore, we wondered if Hcy-activated adventitial fibroblasts might occur through TGF-β production.
Unexpectedly, Hcy, 30 μmol/L, did not induce TGF-β production and secretion during the time examined (Online Figure  IX) . However, Hcy induced a rapid phosphorylation from 10 to 30 minutes in Smad2/3 ( Figure 8A) . In contrast, mitogenactivated protein kinase signaling, including extracellular signal-regulated kinase-activated, protein kinase of 38 kDa (p38)-activated, and c-Jun N-terminal kinase-mitogen-activated protein kinases, was not altered by Hcy. The amplified Smad signaling also was observed in stripped abdominal aortic adventitia of Ang II-infused ApoE −/− mice with HHcy as compared with Ang II alone ( Figure 8B) . Intriguingly, silencing of Smad2 or Smad3 by dominant-negative Smad2 or Smad3 plasmids reversed the Hcy-induced Nox4 upregulation, myofibroblast differentiation, and cytokine production in adventitial fibroblasts ( Figure 8C-8F) . Therefore, Hcy sequentially activated Smad2/3 and Nox4, which contributed to adventitial fibroblast activation.
Hcy Lowering by Folic Acid Reversed HHcy-Aggravated Ang II-Induced AAA In Vivo
To further verify the causal role of HHcy on Ang II-induced AAA, we determined the effect of Hcy lowering by folic acid on HHcy-aggravated AAA in Ang II-stimulated ApoE −/− mice. Table VI , Hcy supplement at 0, 0.9 g/L, or 1.8 g/L in ApoE −/− mice resulted in 8.12±2.58 μmol/L, 16.24±4.48 μmol/L, or 23.52±3.53 μmol/L of plasma Hcy level, respectively. In accordance, the incidence and severity of Ang II−induced AAA were gradually increased with Hcy level (Online Figures XA and XB) , although the effect of 0.9 g/L Hcy treatment did not reach statistical significance compared with that of no Hcy supplement. Intriguingly, supplementation of 0.071 μg/g per day of folic acid in Hcy-treated (1.8 g/L) and Ang II−infused ApoE −/− mice (comparable with 5 mg/70 kg per day in human dose) resulted in a markedly reduced plasma Hcy level and greatly diminished incidence and severity of HHcy-aggravated AAA (folic acid+Hcy+Ang II versus Hcy+Ang II, 50% versus 92.3%; P<0.05; Online Table  VII and Online Figure XB) . Moreover, folic acid treatment dramatically reduced the maximal abdominal aortic diameter, elastin degradation, inflammatory cell infiltration, and MCP-1/IL-6 production in the adventitia of suprarenal aorta (Online Figure XC−XF) . Together, our data strongly suggest Hcy lowering by folic acid rescued HHcy-aggravated adventitial inflammation and Ang II-induced AAA formation.
As shown in Online
Discussion
Epidemiological studies have suggested an association of HHcy and AAA, but discrepancies exist. In addition, we lack direct evidence supporting a causal role. Herein, we demonstrated that HHcy contributes to development of Ang II-induced AAA and rupture. Hcy supplement results in clinically relevant mild HHcy, a large increase in fatal aortic rupture, and formation of nonfatal aneurysm; enlarged aortic aneurysms formed in the Ang II-induced mouse aneurysm model. Reciprocally, folic acid supplement reversed HHcyaggravated Ang II-induecd AAA formation. This study suggests the potential promising benefit of the Hcy-lowering strategy for patients with aortic aneurysm.
A number of multicenter, prospective, case-control studies have been performed to demonstrate HHcy as an independent risk factor of coronary artery disease and stroke. 4, 5, 23 In addition, mounting evidence has suggested that a decrease in serum Hcy level reduces the risk of coronary heart disease and stroke, although the benefit of lowering Hcy level by daily folic acid is not conclusive. 4, 24 In contrast, little is known about the causal role of HHcy in aneurysm formation, expansion, or rupture. Several case-control studies reported an association between increased levels of Hcy and AAA. [6] [7] [8] [9] [10] However, in a recent double-blind controlled trial, treatment with the highdose multivitamin reduced Hcy but did not reduce a composite cardiovascular disease outcome, including AAA repair in kidney transplant recipients. 25 In addition, data showing that low plasma concentration of vitamin B6, rather than Hcy, as a risk factor of AAA in a retrospective study were inconclusive. 11 Moreover, genotypic analysis of the association of methylenetetrahydrofolate reductase and aortic aneurysm was controversial. 12, 13 The complexity of HHcy on cardiovascular risk may be confounded by nonprospective designs, small patient sample sizes, or variance between subgroups analysis. 26 Single studies may have been underpowered to detect overall effects. Given the amount of accumulated data, quantitative synthesis of evidence was necessary to solve the problem of inadequate statistical power and inconsistent results. Our meta-analysis, although with limited studies, revealed a strong association between HHcy andAAA. The between-study heterogeneity was possible because of factors such as country or smoking habit (Online Table II ). Previously, a few studies suggested that increased Hcy level enhanced proteolysis of SM cells or the aortic wall, which may be relevant to AAA. 27, 28 Herein, we provide the first experimental evidence supporting a causal link between HHcy and AAA. Of note, the mild increase in plasma concentration of Hcy in ApoE −/− mice is comparable with that found in AAA patients. 29 Further definitive large-scale prospective clinical studies are crucial to test whether folic acid supplement can reverse the deleterious effect of HHcy on AAA in humans.
Intriguingly, we found that HHcy amplified Ang II-induced adventitial inflammation. Inflammatory cells (eg, macrophages, T lymphocytes, and B lymphocytes) are mainly observed in the tunica adventitia of human aneurismal tissues. In addition, the pathogenesis of AAA is possibly initiated by the macrophage recruitment into the adventitia, and then in the media. 18, 19 Moreover, recent data show that the proinflammatory cytokines IL-6 and MCP-1, which orchestrate monocyte/ macrophage recruitment and activation and mediate vascular inflammation in AAA, are preferentially produced in the adventitial layer. 21, 30 An adventitial IL-6/MCP-1 amplification loop accelerates vascular inflammation, which leads to aortic dissection in Ang II-infused mice. 20 Together, these data support adventitial inflammation playing a key role in the genesis and maintenance of vascular inflammation in aortic aneurysm. In accordance, we found that HHcy amplified Ang II-induced macrophage infiltration, IL-6 and MCP-1 production, and proteolysis activity preferentially in tunica adventitia, which strongly suggests that Hcy may promote aortic aneurysm, at least in part by adventitial activation.
Nevertheless, other possibilities may account for the detrimental effect of Hcy on aneurysm. For instance, we previously demonstrated that Hcy affects the immunoinflammatory response by stimulating chemokine/cytokine secretion in monocytes and T lymphocytes and repressing regulatory T-cell function, 31, 32 whereas a deregulated immune response is involved in the cause of aortic aneurysm. 33 In addition, other groups have reported that HHcy induces endothelial and SM dysfunction, triggers oxidative stress or endoplasmic reticulum stress, decreases the bioavailability of nitric oxide, and modulates the levels of other metabolites, including S-adenosyl methionine and S-adenosyl Hcy, which may result in coronary artery disease, hypertension, or stroke. 34, 35 Whether these mechanisms contribute to HHcyaggravated aneurysm remains for further investigation.
Besides leukocyte infiltration and cytokine production, the adventitia is highly reactive to the process of aneurysm formation, with marked adventitial fibroblasts activation. 36 Little is known about the contribution of adventitial fibroblasts to vascular inflammation during aneurysm. However, emerging evidence has suggested that: adventitial fibroblasts are an active sentinel and respond early during vascular injury; they are capable of proliferation, migration, and transforming into α-actin-positive myofibroblasts; and they produce October 26, 2012 abundant ROS, proinflammatory cytokines, and growth factors, which may contribute to vascular inflammation and cardiovascular disease, such as postinjury restenosis. [37] [38] [39] Recently IL-6 accumulation was found colocalized with both adventitial fibroblasts and activated macrophages in aortic cross-sections of Ang II-infused mice. 30 Also, aortic adventitial fibroblasts participate in Ang II-induced vascular wall inflammation and remodeling, and adventitial fibroblastsleukocyte interaction further amplified this response. 20, 21 Concomitantly, we observed colocalization of IL-6 and MCP-1 with both adventitial fibroblasts and macrophages in adventitia of HHcy Ang II-infused ApoE -/mice. However, the expression in the adventitial fibroblasts was greater than that in the macrophages. Importantly, we showed that Hcy sequentially activated adventitial fibroblast ROS production, myofibroblast differentiation, IL-6 and MCP-1 production, and monocyte/macrophage recruitment, which indicates that adventitial fibroblasts may act as an initiator of adventitial inflammation. Of note, Hcy-induced transition of adventitial fibroblasts to myofibroblasts preceded cytokine production, and inhibition of adventitial fibroblasts dedifferentiation by ROS scavenger (diphenyliodonium or catalase) circumvented Hcy-stimulated IL-6/MCP-1 production and subsequent monocyte/macrophage recruitment. These findings highlight the importance of adventitial fibroblast phenotype transition during Hcy-triggered vascular inflammation.
Previously, NADPH oxidase-derived ROS was suggested to mediate transition of adventitial fibroblasts to myofibroblasts induced by Ang II and TGF-β. [40] [41] [42] Among the Nox isoforms we examined in the adventitial fibroblasts that Nox4 expression was preferentially upregulated by Hcy, and Nox4 silencing greatly inhibited the adventitial fibroblasts phenotype transition, cytokine production, and monocyte recruitment, which indicates that Nox4 is a key player during Hcy-induced adventitial fibroblast activation and vascular inflammation. In contrast, Ang II stimulates Nox4 in vascular endothelial cells and Nox2 in adventitial fibroblasts, which suggests the cell-dependent distinct response of vascular NADPH with various stimuli. [42] [43] [44] We and others have reported on Hcy-triggered oxidative stress in various cell types. 25, 45 We show here for the first time that Hcy induced adventitial fibroblasts oxidative stress through Nox4. In contrast to other isoforms of the NADPH oxidase family, Nox4 does not require the conventional cytoplasmic subunit p47 phox and p67 phox or its homologues for activation. The regulatory mechanism of Nox4 activation remains enigmatic. 45 We show that Hcy activated phospho-Smad 2/3 as early as 10 minutes after treatment without interfering with mitogen-activated protein kinases signaling. Smad2/3 constitutes canonical signaling of TGF-β, a potent inducer of differentiation of fibroblast to myofibrobalst. 46 However, Hcy-activated Smad2/3 seems to be irrelevant to TGF-β because Hcy did not stimulate TGF-β production. Recent studies have identified 47 The importance of adventitial fibroblast Smad2/3 activation in HHcy-aggravated aortic aneurysm remained elusive. Nevertheless, Smad2/3 silencing circumvented Hcy-induced adventitial fibroblast activation, suggesting its potential effect in HHcy-aggravated aortic aneurysm. Smad-mediated Nox4 upregulation was reported recently in TGF-β-induced activation of kidney fibroblasts. 48 However, others have suggested that Nox4-derived ROS activates Smad2/3 and mediates TGF-β-induced transition of cardiac fibroblasts to myofibroblasts and activation. The discrepancy may be because of the different cell types tested or existence of forward feedback of the signaling cascades. The molecular mechanism of Hcy stimulation of Smad2/3 and Nox4 upregulation needs to be further defined.
In summary, we have shown a strong association between HHcy and AAA by meta-analysis and provided the first experimental evidence that HHcy aggravates aortic aneurysm formation, at least in part, by activating adventitial fibroblasts through Nox4. We highlight the potential importance of HHcy and adventitial inflammation in pathogenesis and development of AAA.
